Zevra Therapeutics (ZVRA) Amortization - Intangibles (2023 - 2026)

Zevra Therapeutics (ZVRA) has 4 years of Amortization - Intangibles data on file, last reported at $316000.0 in Q1 2026.

• Quarterly Amortization - Intangibles fell 80.43% year-over-year to $316000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (down 59.46% YoY) and the FY2025 annual result came in at $3.9 million, down 38.06% from the prior year.
• Amortization - Intangibles steadied at $316000.0 in Q1 2026, from $316000.0 in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $1.6 million in Q4 2024 to a low of $315000.0 in Q3 2025.
• A 4-year average of $1.1 million and a median of $1.5 million in 2024 frame the typical range for Amortization - Intangibles.
• Annual changes were most pronounced in 2024 — Amortization - Intangibles soared 109.33% — and 2025, when it plunged 80.45%.
• Tracing ZVRA's Amortization - Intangibles over 4 years: stood at $772000.0 in 2023, then jumped by 109.33% to $1.6 million in 2024, then sank by 80.45% to $316000.0 in 2025, then changed by 0.0% to $316000.0 in 2026.
• The last three Amortization - Intangibles figures came in at $316000.0 (Q1 2026), $316000.0 (Q4 2025), and $315000.0 (Q3 2025), per Business Quant data.